S. Ali: "İtibarsızlaştırılan Covid tedavisi yaklaşık 500.000 kişinin hayatını - 2": İtibarsızlaştırılan Covid tedavisi yaklaşık 500.000 kişinin hayatını - 2 During the 28-day trial, which involved 3,885 patients with lifethreatening Covid infection, 352 were given the drug and the rest had standard treatment. Just 16.8 percent in the drug group died compared to 25.9 percent in the standard care group. Hydroxychloroguine, marketed as Plaquenil, regulates an overactive immune system, which was characterized as a "cytokine storm" during Covid infection. Patients who didn't receive it as part of their treatment had a 57 percent higher risk of death across all age groups in the study, the researchers said. Hydroxychloroquine was championed by then president Donald Trump, who said he was given the drug to treat his own Covid infection, but a study—later found to be fraudulent—had claimed it was ineffective. Critics have claimed the study was designed to fail as new vaccines cannot be fast-tracked if an effective treatment already exists.

During the 28-day trial, which involved 3,885 patients with lifethreatening Covid infection, 352 were given the drug and the rest had standard treatment. Just 16.8 percent in the drug group died compared to 25.9 percent in the standard care group. Hydroxychloroguine, marketed as Plaquenil, regulates an overactive immune system, which was characterized as a "cytokine storm" during Covid infection. Patients who didn't receive it as part of their treatment had a 57 percent higher risk of death across all age groups in the study, the researchers said. Hydroxychloroquine was championed by then president Donald Trump, who said he was given the drug to treat his own Covid infection, but a study—later found to be fraudulent—had claimed it was ineffective. Critics have claimed the study was designed to fail as new vaccines cannot be fast-tracked if an effective treatment already exists.

Sayfa 19Kitabı okudu

What Doctors Don't Tell You UK - February 2024 Kolektif

58 görüntüleme

Öne Çıkan Yorum

S. Ali

@aynabeyan ·

07 Nisan 11:57

Hayatı tehdit eden Covid enfeksiyonu olan 3.885 hastanın dahil edildiği 28 günlük deneme sırasında 352'sine ilaç verildi ve geri kalanına standart tedavi uygulandı. Standart bakım grubundaki yüzde 25,9'a kıyasla ilaç grubundaki hastaların sadece yüzde 16,8'i hayatını kaybetti. Plaquenil olarak pazarlanan Hydroxychloroguine, Covid enfeksiyonu sırasında "sitokin fırtınası" olarak nitelendirilen aşırı aktif bir bağışıklık sistemini düzenler. Araştırmacılar, tedavilerinin bir parçası olarak bunu almayan hastaların, çalışmadaki tüm yaş gruplarında yüzde 57 daha yüksek ölüm riskine sahip olduğunu söyledi. Hidroksiklorokin, kendisine Covid enfeksiyonunu tedavi etmesi için ilaç verildiğini söyleyen dönemin başkanı Donald Trump tarafından savunulmuş, ancak daha sonra hileli olduğu anlaşılan bir çalışmada etkisiz olduğu iddia edilmişti. Eleştirmenler ilacın çalışma başarısız olacak şekilde tasarlanmıştır çünkü etkili bir tedavi zaten mevcutsa yeni aşılar hızlı bir şekilde uygulanamaz.

Yorum yapabilmeniz için giriş yapmanız gerekmektedir.

Gönderi

S. Ali